Last reviewed · How we verify

RDC Clinical Pty Ltd — Portfolio Competitive Intelligence Brief

RDC Clinical Pty Ltd pipeline: 7 marketed, 0 filed, 6 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

7 marketed 0 filed 6 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

DrugGenericPhaseClassTargetAreaFirst approval
Product 1 - AquaCelle Fish Oil Triglyceride Product 1 - AquaCelle Fish Oil Triglyceride marketed
Product 2 - AquaCelle Fish Oil Ethyl Ester Product 2 - AquaCelle Fish Oil Ethyl Ester marketed Omega-3 fatty acid supplement / Triglyceride-lowering agent Multiple targets including PPAR-alpha, GPR120, and hepatic lipid metabolism pathways Cardiovascular
PlexoZome® Levagen® topical spray solution PlexoZome® Levagen® topical spray solution marketed
Palm Oil capsule Palm Oil capsule marketed
Placebo comparator - Microcrystalline cellulose Placebo comparator - Microcrystalline cellulose marketed
Levagen+ Levagen+ marketed Immunostimulant Immune cell activation (non-specific) Dermatology / Wound Care
Product 3 - Standard Fish Oil Triglyceride Product 3 - Standard Fish Oil Triglyceride marketed Omega-3 fatty acid supplement Cardiovascular
Testofen Testofen phase 3 Other
Maolactin Maolactin phase 3 Other
Low Dose Maolactin Low Dose Maolactin phase 3 macrolide antibiotic 50S ribosomal subunit Infectious diseases
Food-Grown Magnesium Food-Grown Magnesium phase 3 Mineral supplement / Nutritional product Nutritional supplementation / General wellness
High Dose Maolactin High Dose Maolactin phase 3 Immunomodulator Infectious Diseases

Therapeutic area mix

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

  1. Actavis Mid-Atlantic LLC · 1 shared drug class
  2. Active Biotech AB · 1 shared drug class
  3. Air Force Military Medical University, China · 1 shared drug class
  4. Assistance Publique - Hôpitaux de Paris · 1 shared drug class
  5. Astellas Pharma Inc · 1 shared drug class
  6. Bayer · 1 shared drug class
  7. Beijing Children's Hospital · 1 shared drug class
  8. ALK-Abelló A/S · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for RDC Clinical Pty Ltd:

Cite this brief

Drug Landscape (2026). RDC Clinical Pty Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/rdc-clinical-pty-ltd. Accessed 2026-05-16.

Related